Cardlytics (CDLX) Change in Accured Expenses (2017 - 2026)

Cardlytics' Change in Accured Expenses history runs 10 years deep, the most recent figure standing at $586000.0 for Q1 2026.

• Quarterly Change in Accured Expenses fell 69.08% year-over-year to $586000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.0 million (down 170.47% YoY) and the FY2025 annual result came in at -$724000.0, up 89.1% from the prior year.
• Change in Accured Expenses was $586000.0 for Q1 2026 at Cardlytics, up from -$2.5 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $5.8 million in Q2 2022 and bottomed at -$11.6 million in Q1 2022.
• A 5-year average of -$1.4 million and a median of -$44000.0 in 2022 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 1261.55% — and 2023, when it surged 1627.27%.
• Cardlytics' Change in Accured Expenses stood at -$3.7 million in 2022, then surged by 175.36% to $2.8 million in 2023, then slumped by 223.73% to -$3.5 million in 2024, then advanced by 27.98% to -$2.5 million in 2025, then surged by 123.57% to $586000.0 in 2026.
• Business Quant data shows CDLX's Change in Accured Expenses at $586000.0 in Q1 2026, -$2.5 million in Q4 2025, and $842000.0 in Q3 2025.